Видео ютуба по тегу Tki Treatment

Chronic Myeloid Leukemia (CML) - Treatment - Tyrosine Kinase (TK) Inhibitors
Chronic Myeloid Leukemia (CML) - Treatment - Tyrosine Kinase (TK) Inhibitors
Stopping TKI in children with CML
Stopping TKI in children with CML
CML - Side effects of TKI treatment
CML - Side effects of TKI treatment
Current CML treatments: which TKI to choose?
Current CML treatments: which TKI to choose?
Managing Toxicities of Tyrosine Kinase Inhibitors (TKI) in CML - Drs. Onyee Chan & Fadi Haddad
Managing Toxicities of Tyrosine Kinase Inhibitors (TKI) in CML - Drs. Onyee Chan & Fadi Haddad
Understanding NSCLC Treatment When You Have an EGFR Mutation
Understanding NSCLC Treatment When You Have an EGFR Mutation
Resistance to Targeted-TKI Treatment in Patients With CML
Resistance to Targeted-TKI Treatment in Patients With CML
CML as an Ideal Cancer for Targeted Therapy With TKI
CML as an Ideal Cancer for Targeted Therapy With TKI
Advancing CML and Leukemia Care with TKIs, CAR-T, and AI – Dr. Elias Jabbour
Advancing CML and Leukemia Care with TKIs, CAR-T, and AI – Dr. Elias Jabbour
Balancing Cost and Care First Line TKI Decisions in CML Treatment – Dr. Elias Jabbour
Balancing Cost and Care First Line TKI Decisions in CML Treatment – Dr. Elias Jabbour
Taking Your TKI / CML and Tyrosine Kinase Inhibitors / Chronic Myeloid Leukemia Treatment
Taking Your TKI / CML and Tyrosine Kinase Inhibitors / Chronic Myeloid Leukemia Treatment
Curing Chronic Myeloid Leukaemia | Professor Tim Hughes
Curing Chronic Myeloid Leukaemia | Professor Tim Hughes
Dr. Shah on TKI Treatment Discontinuation in CML
Dr. Shah on TKI Treatment Discontinuation in CML
The feasibility of TKI treatment discontinuation in patients with Ph+ ALL
The feasibility of TKI treatment discontinuation in patients with Ph+ ALL
Dose-Reductions in Second-Line TKI Treatment of HCC
Dose-Reductions in Second-Line TKI Treatment of HCC
TKI-related toxicities in CML & the importance of long-term monitoring
TKI-related toxicities in CML & the importance of long-term monitoring
Debate: CML in MMR: Should You Stop TKI Treatment?
Debate: CML in MMR: Should You Stop TKI Treatment?
CML Treatment Options / Chronic Myeloid Leukemia Treatment Options / CML Treatment / TKI
CML Treatment Options / Chronic Myeloid Leukemia Treatment Options / CML Treatment / TKI
Barriers to TKI discontinuation in patients with CML
Barriers to TKI discontinuation in patients with CML
Is it possible to achieve TFR with low-dose TKI therapy?
Is it possible to achieve TFR with low-dose TKI therapy?
ENESTop: deep molecular response in CML can be translated into treatment-free remission
ENESTop: deep molecular response in CML can be translated into treatment-free remission
EURO-SKI trial: cessation of TKI treatment in CML patients with deep molecular response
EURO-SKI trial: cessation of TKI treatment in CML patients with deep molecular response
Mechanisms of Resistance to EGFR TKI and New Treatment Strategies
Mechanisms of Resistance to EGFR TKI and New Treatment Strategies
Predictors for TFR in CML: response duration, secondary treatment & frontline TKI choice
Predictors for TFR in CML: response duration, secondary treatment & frontline TKI choice
Managing cardiovascular risks associated with lifelong TKI therapy in CML
Managing cardiovascular risks associated with lifelong TKI therapy in CML